Technology
Choose a subcategory:
Icagen's ability to raise additional funding; Icagen's history of net losses and how long Icagen will be able to operate on its existing capital resources; general economic and financial market conditions; Icagen's ability to maintain compl
China Nuokang Bio-Pharmaceutical Inc. is a leading biopharmaceutical company in China focused on the research, development, manufacture, marketing and sales of hospital-based medical products.
To read the entire report visit: www.microstockprofit. com/lp/ OREX See what investors are saying about OREX at http:// www.stockhideout. com Get breaking news on OREX at http:// thestockmarketwatch. com/ MicroStockProfit. com is a small-ca
About Regenicin Regenicin, Inc. is a development-stage company focusing on next-generation tissue-engineered skin substitutes to restore the qualities of healthy human skin.
Neptune Technologies & Bioressources Inc. Andre Godin, Vice President, Finance & Administration 450-687- 2262 a. godin@ neptunebiotech. com www.neptunebiotech. com Acasti Pharma Inc. Tina Sampalis, President 450-686- 4555 t. sampalis@ acast
Nidec Corporation Announces Notice of Determination of the Terms of Issuance of Euro Yen Convertible
KYOTO, Japan, Sept. 2, 2010 ( GLOBE NEWSWIRE)- Nidec Corporation ( the " Company") announced today that it had determined the terms of the issuance with regard to the issuance of the Euro Yen Convertible-Bonds-Type Bonds with Stock Acquisit
Generex claims the protection of the safe harbor for forward-looking statements that is contained in the Private Securities Litigation Reform Act.
These risks and uncertainties include, but are not limited to: the risk that we may be unable to further identify, develop and achieve commercial success for new products and technologies; the risk that we may be unable to discover drugs th
Reports include: REGULATORY & COMPLIANCE NEWS Friction Factor- market-maker surveillance system tracking market-makers in all stocks to determine Price Friction and compliance with new " Fair Market-Making Requirements" RegSHO Naked Shorts-
These risks, including those related to inability to comply with NASDAQ's continued listing requirements; the generally unstable nature of current economic and financial market conditions; the results of discovery research and pre-clinical
Neptune Technologies & Bioressources Inc. Andre Godin, Vice President, Finance & Administration 450-687- 2262 a. godin@ neptunebiotech. com www.neptunebiotech. com Acasti Pharma Inc. Tina Sampalis, President 450-686- 4555 t. sampalis@ acast
Mr. Yu plans to implement immediately the following strategic initiatives:- Identify strategic acquisition and investment opportunities in high-growth industries- Build a results-oriented management team- Execute strategic transactions inte